Benjamin F. Edwards & Company’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.03M | Buy |
13,347
+91
| +0.7% | +$6.66K | 0.02% | 516 |
|
|
2024
Q1 | $908K | Sell |
13,256
-84
| -0.6% | -$5.4K | 0.02% | 529 |
|
|
2023
Q4 | $771K | Buy |
13,340
+1,987
| +18% | +$106K | 0.02% | 545 |
|
|
2023
Q3 | $599K | Buy |
11,353
+1,914
| +20% | +$100K | 0.02% | 480 |
|
|
2023
Q2 | $511K | Hold |
9,439
| – | – | 0.02% | 507 |
|
|
2023
Q1 | $472K | Sell |
9,439
-3
| -0% | -$141 | 0.02% | 497 |
|
|
2022
Q4 | $437K | Sell |
9,442
-9
| -0.1% | -$390 | 0.02% | 496 |
|
|
2022
Q3 | $366K | Sell |
9,451
-387
| -4% | -$15.5K | 0.02% | 499 |
|
|
2022
Q2 | $367K | Sell |
9,838
-146
| -1% | -$5.94K | 0.02% | 504 |
|
|
2022
Q1 | $442K | Sell |
9,984
-722
| -7% | -$31.3K | 0.02% | 484 |
|
|
2021
Q4 | $455K | Sell |
10,706
-188
| -2% | -$7.9K | 0.02% | 482 |
|
|
2021
Q3 | $473K | Hold |
10,894
| – | – | 0.02% | 458 |
|
|
2021
Q2 | $466K | Sell |
10,894
-9
| -0.1% | -$379 | 0.02% | 458 |
|
|
2021
Q1 | $421K | Buy |
10,903
+709
| +7% | +$26.8K | 0.02% | 496 |
|
|
2020
Q4 | $366K | Sell |
10,194
-167
| -2% | -$6.02K | 0.02% | 499 |
|
|
2020
Q3 | $396K | Buy |
10,361
+2,283
| +28% | +$88K | 0.03% | 446 |
|
|
2020
Q2 | $284K | Sell |
8,078
-82
| -1% | -$2.95K | 0.02% | 492 |
|
|
2020
Q1 | $266K | Buy |
8,160
+747
| +10% | +$29.2K | 0.02% | 456 |
|
|
2019
Q4 | $335K | Buy |
7,413
+47
| +0.6% | +$1.97K | 0.02% | 482 |
|
|
2019
Q3 | $300K | Sell |
7,366
-30
| -0.4% | -$1.27K | 0.02% | 469 |
|
|
2019
Q2 | $318K | Buy |
7,396
+480
| +7% | +$18.5K | 0.03% | 439 |
|
|
2019
Q1 | $265K | Buy |
6,916
+300
| +5% | +$11.5K | 0.02% | 457 |
|
|
2018
Q4 | $234K | Buy |
6,616
+2,405
| +57% | +$87.2K | 0.02% | 452 |
|
|
2018
Q3 | $162K | Buy |
4,211
+3,911
| +1,304% | +$137K | 0.02% | 568 |
|
|
2018
Q2 | $10K | Sell |
300
-400
| -57% | -$12.1K | ﹤0.01% | 1261 |
|
|
2018
Q1 | $19K | Sell |
700
-600
| -46% | -$16.3K | ﹤0.01% | 1085 |
|
|
2017
Q4 | $32K | Buy |
1,300
+996
| +328% | +$27.5K | ﹤0.01% | 905 |
|
|
2017
Q3 | $9K | Buy |
304
+4
| +1% | +$110 | ﹤0.01% | 1179 |
|
|
2017
Q2 | $8K | Hold |
300
| – | – | ﹤0.01% | 1136 |
|
|
2017
Q1 | $7K | Hold |
300
| – | – | ﹤0.01% | 1096 |
|
|
2016
Q4 | $6K | Sell |
300
-127
| -30% | -$2.77K | ﹤0.01% | 1025 |
|
|
2016
Q3 | $10K | Hold |
427
| – | – | ﹤0.01% | 841 |
|
|
2016
Q2 | $10K | Buy |
427
+127
| +42% | +$2.75K | ﹤0.01% | 795 |
|
|
2016
Q1 | $6K | Hold |
300
| – | – | ﹤0.01% | 883 |
|
|
2015
Q4 | $6K | Hold |
300
| – | – | ﹤0.01% | 933 |
|
|
2015
Q3 | $5K | Hold |
300
| – | – | ﹤0.01% | 985 |
|
|
2015
Q2 | $5K | Hold |
300
| – | – | ﹤0.01% | 1025 |
|
|
2015
Q1 | $5K | Hold |
300
| – | – | ﹤0.01% | 990 |
|
|
2014
Q4 | $4K | Hold |
300
| – | – | ﹤0.01% | 910 |
|
|
2014
Q3 | $4K | Sell |
300
-530
| -64% | -$6.67K | ﹤0.01% | 877 |
|
|
2014
Q2 | $11K | Sell |
830
-10
| -1% | -$130 | ﹤0.01% | 711 |
|
|
2014
Q1 | $11K | Buy |
840
+640
| +320% | +$8.4K | ﹤0.01% | 667 |
|
|
2013
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 854 |
|
|
2013
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 765 |
|
|
2013
Q2 | $2K | Buy |
+200
| New | +$1.7K | ﹤0.01% | 731 |
|
Other funds holding BSX
Benjamin F. Edwards & Company's BSX Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its Boston Scientific (BSX) stake by 0.69% in Q2 2024, buying an estimated $6.66K and bringing the position to 13,347 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #516.
Benjamin F. Edwards & Company first reported a position in BSX in Q2 2013 and has held it in 45 quarters since. 1,321 funds tracked by Wall St. Rank hold BSX as of Q2 2024.
- Benjamin F. Edwards & Company held 13,347 shares of Boston Scientific worth $1.03M as of Q2 2024.
- Benjamin F. Edwards & Company bought 91 Boston Scientific shares in Q2 2024, an estimated $6.66K.
- Boston Scientific made up 0.02% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #516 holding.
- Benjamin F. Edwards & Company first reported a position in Boston Scientific in Q2 2013 and has held it in 45 quarters since.
- 1,321 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.